Weakly Supervised Classification of Mohs Surgical Sections Using Artificial Intelligence.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
PMID:

Abstract

Basal cell carcinoma (BCC) is the most frequently diagnosed form of skin cancer, and its incidence continues to rise, particularly among older individuals. This trend puts a significant strain on health care systems, especially in terms of histopathologic diagnostics required for Mohs micrographic surgery (MMS), which is used to treat BCC in sensitive locations to minimize tissue loss. This study aims to address the challenges in BCC detection within MMS whole-slide images by developing and evaluating a deep learning model that bridges weakly supervised learning with interpretable segmentation-based methods through attention maps. Utilizing data sets from 2 medical centers, the model demonstrated an average area under the receiver operating characteristic curve (AUC) of 0.958 on internal testing and an AUC of 0.934 on an independent third external data set despite no fine-tuning or preprocessing for the latter. Attention maps provided insights into the model's decision making, highlighting critical regions for slide-level classification. The sensitivity of the attention maps in localizing tumor regions was 0.853 when no filtering was applied and gave 8 revision false positives per slide on average and was reduced to an average of 2 false positives per slide with a sensitivity of 0.873 when detections smaller than 200 μm were removed from the attention maps. These findings indicate that the deep learning model is highly effective in detecting BCC in MMS whole-slide images, with robust performance across different data sets and conditions. The use of attention maps enhances the model's interpretability, making it a promising tool for aiding dermatopathologists and MMS surgeons.

Authors

  • Daan J Geijs
    Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Lisa M Hillen
    Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Stephan Dooper
    Computational Pathology Group, Department of Pathology, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands. Electronic address: stephan.dooper@radboudumc.nl.
  • Veronique Winnepenninckx
    Department of Pathology, GROW-School for Oncology & Developmental Biology, Maastricht University Medical Center, MUMC+, Maastricht, The Netherlands.
  • Vamsi Varra
    The Ohio State University Medical Center, Columbus, Ohio.
  • David R Carr
    The Ohio State University Medical Center, Columbus, Ohio.
  • Kathryn T Shahwan
    The Ohio State University Medical Center, Columbus, Ohio; University of North Dakota Medical School, Grand Forks, North Dakota; Altru Health System, Grand Forks, North Dakota.
  • Geert Litjens
    Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Avital Amir
    Department of Pathology, Research Institute for Medical Innovation and Oncode Institute, Radboud University Medical Center, Nijmegen, The Netherlands.